NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Overview of attention for article published in Journal of Nuclear Medicine, February 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 27 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 85 Mendeley

So far, Altmetric has seen 33 X posts from 27 X users, with an upper bound of 212,605 followers.

RT @NANETS1: NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Ther…

NANETS/SNMMI consensus statement on patient selection and appropriate use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy #GTGJournalWatch https://t.co/klwNeKrWJl

RT @_JosephLi: North American Neuroendocrine Tumor Society publishes Consensus Statement on Pt Selection & Appropriate Use of 177Lu-DOTATA…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 29 additional X posts.